Prostate cancer and treatment choices - a decision shared by doctor and patient?

Key points
- When a man is diagnosed with localised prostate cancer, he usually faces a range of treatment options, from active surveillance to radiation therapy or surgical removal of the prostate.
- The frequent difficulty in determining the prognosis of localised prostate cancer complicates matters.
- The doctor must reach an agreement with the patient when making treatment decisions.
- "Such truly shared decision-making is a relatively new phenomenon in medicine.
When a man is diagnosed with localised prostate cancer, he usually faces a range of treatment options, from active surveillance to radiation therapy or surgical removal of the prostate. The patient's personal values and preferences should be key in this choice: Is curing the cancer the only thing that matters or should he also consider a variety of quality of life issues, such as avoiding incontinence or erectile dysfunction?
The frequent difficulty in determining the prognosis of localised prostate cancer complicates matters. Many men have low risk prostate cancer that is thought to be slowly progressing and may have no impact on their life expectancy.
The doctor must reach an agreement with the patient when making treatment decisions. However, truly shared decision-making is possible only when the patient understands what the different treatment options entail for him personally, and the doctor understands the patient's personal situation and desires.
"Such truly shared decision-making is a relatively new phenomenon in medicine. Traditionally we assumed that the doctor always knows best," says Kari Tikkinen, Academy of Finland clinical researcher and adjunct professor of clinical epidemiology from the Department of Urology at the Helsinki University Hospital.
Discussing prostate cancer diagnoses and treatment options are part of a urologist's everyday work. Tikkinen wanted to examine the impact of decision aids on the treatment decision. His international research group began to explore the issue through a systematic literature review and meta-analysis.
The meta-analysis identified 14 randomised studies that evaluated the impact of decision aids for the patient's choice of localised prostate cancer treatment. Ten of the studies were conducted in North America, three in Europe, and one in Australia. Together, the studies enrolled 3,377 patients. The average age of the participants was between 61 and 69; they represented a broad range of educational and employment backgrounds, and most were in domestic partnerships.
The most common form of decision aid provided to the patients was written information on the different treatment options. Information was also offered as videos, lectures and discussions, and in some cases, interactive computer applications. Fewer than half of the aids provided had been customised in some way to meet that specific patient's individual need for information.
The aids provided were intended for perusal prior to the clinical consultation to determine treatment. In practice, this meant that the patient bore the primary responsibility for studying and understanding the information.
The impact of the decision aids on the perceived difficulty of the decision as well as patient satisfaction and understanding varied from study to study. Use of the aids seemed to have no effect on the use of any individual treatment option, but two studies suggested a modest impact on reducing feelings of regret about the chosen treatment. The studies did not measure the impact of the decision aids on the flow of the decision process, the time spent making the decision or the costs associated with it, nor did they evaluate the impact of the use of the decision aids on the doctor-patient discussion.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsMoffitt Cancer Center Researcher Helps Develop Prostate Cancer Testing, Treatment Guidelines
Julio M. Pow-Sang, M.D., chair of Moffitt Cancer Center's Department of Genitourinary Oncology, and colleagues have published two prostate cancer articles in the September issue of JNCCN - The Journal of the National…
29 September 2012
NewsCloned receptor paves way for new breast and prostate cancer treatment
Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the…
14 September 2012
NewsMore men with prostate cancer "team" wait on treatment
Men with low-risk forms of prostate cancer are more likely to opt for so-called active surveillance over surgery or radiation when they have a multidisciplinary team of doctors working with them, according to a new…



